GMAB

Genmab A/s Health Care Pharmaceutical Preparations Russell 3000
$57.06Close $23.85 – $57.2952-week range Nov 5, 2026Next report · before the open

Highlights

Strengths

  • In a stage-2 uptrend all 8 trend conditions pass
  • Leading the market RS 98 · stronger than 98% of stocks over 12 months
  • RS line at a 1-year high outperforming the S&P 500 more than at any point this year
  • Near its high at its 52-week high
  • Accumulation up-day volume 2.6× down-day volume over 50 sessions

Cautions

  • Extended 12.5 ATR above its 50-day average
  • Results soon Nov 5, 2026, in 4 days

Price

Filing Results Screen pick 52-week high and low Adjusted prices

Trade setup

ATR% 4.3% $2.45 a day · 2×ATR $52.16
RS 98 / 99 vs the universe
Trend 8 / 8 trend template
Relative volume 2.1× vs 50-day average
Up/down volume 2.56 50 sessions
Implied move — no option chain · report Nov 5, 2026
Trend template · 8 of 8

Screen verdict

Not scorable — no annual report on file.

Filings

SEC EDGAR

No readable filings.

Current reports